IPF.L vs. BPCR.L
IPF.L (International Personal Finance plc) and BPCR.L (BioPharma Credit plc) are both stocks. Both are in the Financial Services sector — IPF.L in Credit Services, BPCR.L in Asset Management. Over the past 5 years, IPF.L returned 22.98%/yr vs 16.29%/yr for BPCR.L. At a correlation of -0.01, they often move in opposite directions.
Performance
IPF.L vs. BPCR.L - Performance Comparison
Loading charts...
Different Trading Currencies
IPF.L is traded in GBp, while BPCR.L is traded in USD. To make them comparable, the BPCR.L values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, IPF.L achieves a 9.87% return, which is significantly lower than BPCR.L's 12.51% return.
IPF.L
- 1D
- 0.00%
- 1M
- 0.20%
- YTD
- 9.87%
- 6M
- 26.03%
- 1Y
- 61.25%
- 3Y*
- 40.35%
- 5Y*
- 22.98%
- 10Y*
- 6.64%
BPCR.L
- 1D
- -1.04%
- 1M
- 2.20%
- YTD
- 12.51%
- 6M
- 11.04%
- 1Y
- 27.60%
- 3Y*
- 15.06%
- 5Y*
- 16.29%
- 10Y*
- —
IPF.L vs. BPCR.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IPF.L International Personal Finance plc | 9.87% | 95.18% | 19.42% | 78.14% | -38.34% | 60.72% | -40.04% | -14.69% | 9.90% | 29.14% |
BPCR.L BioPharma Credit plc | 12.47% | 11.25% | 24.34% | -2.54% | 26.77% | 8.91% | 5.60% | 0.69% | 19.43% | -3.31% |
Correlation
The correlation between IPF.L and BPCR.L is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.04 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.02 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.02 |
Correlation (All Time) Calculated using the full available price history since Mar 28, 2017 | -0.01 |
Fundamentals
IPF.L:
£569.66M
BPCR.L:
$1.08B
IPF.L:
£0.50
BPCR.L:
$0.22
IPF.L:
4.95
BPCR.L:
4.32
IPF.L:
0.51
BPCR.L:
0.16
IPF.L:
0.39
BPCR.L:
4.12
IPF.L:
1.04
BPCR.L:
0.94
IPF.L:
£1.46B
BPCR.L:
$264.69M
IPF.L:
£1.28B
BPCR.L:
$267.83M
IPF.L:
£338.70M
BPCR.L:
$57.10M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IPF.L vs. BPCR.L — Risk / Return Rank
IPF.L
BPCR.L
IPF.L vs. BPCR.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for International Personal Finance plc (IPF.L) and BioPharma Credit plc (BPCR.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IPF.L | BPCR.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.26 | ||
| Sortino ratioReturn per unit of downside risk | +2.56 | ||
| Omega ratioGain probability vs. loss probability | 1.75 | 1.36 | +0.38 |
| Calmar ratioReturn relative to maximum drawdown | 7.36 | 4.66 | +2.70 |
| Martin ratioReturn relative to average drawdown | 21.06 | 13.60 | +7.46 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IPF.L | BPCR.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.20 | 1.95 | +0.26 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.56 | 1.10 | -0.54 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.12 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.10 | 0.75 | -0.66 |
Drawdowns
IPF.L vs. BPCR.L - Drawdown Comparison
The maximum IPF.L drawdown since its inception was -92.28%, which is greater than BPCR.L's maximum drawdown of -19.11%. Use the drawdown chart below to compare losses from any high point for IPF.L and BPCR.L.
Loading charts...
Drawdown Indicators
| IPF.L | BPCR.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.28% | -19.11% | -73.17% |
Max Drawdown (1Y)Largest decline over 1 year | -8.26% | -5.90% | -2.36% |
Max Drawdown (3Y)Largest decline over 3 years | -24.30% | -11.04% | -13.26% |
Max Drawdown (5Y)Largest decline over 5 years | -54.90% | -19.11% | -35.79% |
Max Drawdown (10Y)Largest decline over 10 years | -85.82% | — | — |
Current DrawdownCurrent decline from peak | -12.62% | -1.38% | -11.24% |
Average DrawdownAverage peak-to-trough decline | -46.99% | -4.38% | -42.61% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.89% | 2.02% | +0.87% |
Volatility
IPF.L vs. BPCR.L - Volatility Comparison
The current volatility for International Personal Finance plc (IPF.L) is 0.68%, while BioPharma Credit plc (BPCR.L) has a volatility of 3.18%. This indicates that IPF.L experiences smaller price fluctuations and is considered to be less risky than BPCR.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IPF.L | BPCR.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.68% | 3.18% | -2.50% |
Volatility (6M)Calculated over the trailing 6-month period | 12.80% | 10.35% | +2.45% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.57% | 14.14% | +13.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 41.10% | 14.85% | +26.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 53.31% | 14.34% | +38.97% |
Dividends
IPF.L vs. BPCR.L - Dividend Comparison
IPF.L's dividend yield for the trailing twelve months is around 5.16%, less than BPCR.L's 14.04% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BPCR.L BioPharma Credit plc | 14.04% | 13.78% | 14.99% | 15.79% | 14.30% | 10.39% | 10.73% | 8.96% | 10.10% | 2.56% | 0.00% | 0.00% |
IPF.L International Personal Finance plc | 5.16% | 5.04% | 8.15% | 8.07% | 11.63% | 1.71% | 9.57% | 7.70% | 6.03% | 6.28% | 7.20% | 4.29% |
Financials
IPF.L vs. BPCR.L - Financials Comparison
This section allows you to compare key financial metrics between International Personal Finance plc and BioPharma Credit plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
IPF.L vs. BPCR.L - Profitability Comparison
IPF.L - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, International Personal Finance plc reported a gross profit of 374.80M and revenue of 389.70M. Therefore, the gross margin over that period was 96.2%.
BPCR.L - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, BioPharma Credit plc reported a gross profit of 47.36M and revenue of 63.08M. Therefore, the gross margin over that period was 75.1%.
IPF.L - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, International Personal Finance plc reported an operating income of 75.20M and revenue of 389.70M, resulting in an operating margin of 19.3%.
BPCR.L - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, BioPharma Credit plc reported an operating income of 57.09M and revenue of 63.08M, resulting in an operating margin of 90.5%.
IPF.L - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, International Personal Finance plc reported a net income of 23.20M and revenue of 389.70M, resulting in a net margin of 6.0%.
BPCR.L - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, BioPharma Credit plc reported a net income of 57.10M and revenue of 63.08M, resulting in a net margin of 90.5%.
Frequently Asked Questions
IPF.L and BPCR.L have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for IPF.L and BPCR.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer